Name: SXTC Balance Sheet - China Sxt Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SXTC - China Sxt Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

SXTC Balance Sheet - China Sxt Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash And Short Term Investments
Cash And Equivalents	28.2	18.1	12.1	17.4	-	13.4	7.3	9.3	0.7	0.1	0.0
Restricted Cash	0.0	0.0	0.0	-	0.0	0.0	-	0.2	0.1	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	28.2	18.1	12.1	17.4	-	13.4	7.3	9.3	0.7	0.1	0.0
Receivables
Accounts Receivable	0.9	1.3	1.3	1.3	3.3	4.5	3.8	4.2	2.6	-	-
Current Assets
Inventory	0.8	0.8	0.8	0.5	1.0	0.9	0.9	1.0	1.3	-	-
Prepaid Expenses	0.4	0.3	0.0
Non-Current Assets
Property, Plant & Equipment Gross	2.7	2.6	2.8	2.9	3.0	2.9	2.6	1.9	-	-	-
Accumulated Depreciation	2.2
Current Liabilities
Accounts Payable	0.5	1.2	1.3	1.4	1.5	1.5	1.9	1.7	2.4	-	-
Short Term Debt	0.4	0.0	0.0
Non-Current Liabilities
Long Term Debt	0.6	0.1	0.1	0.1	-	0.0	0.0	0.0	-	-	-
Operating Lease Liabilities Non-Current	-	-
Common Equity
Common Stock	64.1	44.5	39.7	0.9	0.2	0.1	0.0	0.0	0.0	-	-
Additional Paid In Capital	-	-	-
Supplementary Data
Total Debt	1.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	-	-	-
Net debt	(27.2)	(18.0)	(11.9)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q4 FY 26	Q2 FY 26	Q4 FY 25	Q2 FY 25	Q4 FY 24	Q2 FY 24	Q4 FY 23	Q2 FY 23	Q4 FY 22	Q2 FY 22	Q4 FY 21	Q2 FY 21	Q4 FY 20	Q2 FY 20	Q4 FY 19	Q2 FY 19	Q4 FY 18	Q4 FY 17
Cash And Short Term Investments
Cash And Equivalents	28.2	21.2	18.1	18.5	12.1	11.5	17.4	3.0	15.5	0.0	13.3	10.4	7.3	8.2	9.1	0.4	0.6
Restricted Cash	0.0	0.0	0.0	-	0.0	-	-	-	0.0	-	0.0	-	-	0.1	0.2	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	28.2	21.2	18.1	18.5	12.1	11.5	17.4	3.0	15.5	0.0	13.3	10.4	7.3	8.2	9.1
Receivables
Accounts Receivable	0.9	1.3	1.3	1.7	1.3	1.3	1.3	3.3	3.3	3.9	4.5	5.6	3.8	4.6	4.2
Current Assets
Inventory	0.8	0.8	0.8	0.9	0.8	0.5	0.5	0.6	1.0	0.8	0.9	0.9	0.9	0.8	1.0	-
Non-Current Assets
Property, Plant & Equipment Gross	2.7	2.7	2.6	-	-	2.7	2.9	2.7	3.0	3.0	2.9	2.7	2.6	-
Current Liabilities
Accounts Payable	0.5	0.5	1.2	1.7	1.3	1.3	1.4	1.6	1.5	1.5	1.5	1.4	1.9	2.0	1.7
Non-Current Liabilities
Long Term Debt	0.6	0.1	0.1	0.1	0.1	0.1	0.1	-	-	-	0.0	0.0	0.0	0.1	0.0	-
Common Equity
Common Stock	64.1	55.4	44.5	7.7	4.4	1.5	0.9	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	-
Supplementary Data
Total Debt	1.0	0.1	0.1	0.1	0.1	0.1	0.1	-	0.0	0.0	0.0	0.1	0.1	0.1	0.1	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)